These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15161956

  • 1. A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy.
    Stoves J, Newstead CG, Baczkowski AJ, Owens G, Paraoan M, Hammad AQ.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2113-20. PubMed ID: 15161956
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy.
    Henne T, Latta K, Strehlau J, Pape L, Ehrich JH, Offner G.
    Transplantation; 2003 Nov 15; 76(9):1326-30. PubMed ID: 14627911
    [Abstract] [Full Text] [Related]

  • 3. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR, Ward MT, Blahut SA, Klassen DK, Cangro CB, Bartlett ST, Fink JC.
    Kidney Int; 2001 Apr 15; 59(4):1567-73. PubMed ID: 11260422
    [Abstract] [Full Text] [Related]

  • 4. Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, El-Baz M, Shokeir AA, Ghoneim MA.
    Ann Transplant; 2008 Apr 15; 13(4):46-54. PubMed ID: 19034223
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
    Sumethkul V, Changsirikulchai S, Lothuvachai T, Chalermsanyakorn P.
    Transplant Proc; 2006 Dec 15; 38(10):3470-2. PubMed ID: 17175307
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep 15; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 15; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 8. The effect of maintenance immunosuppression medication on the change in kidney allograft function.
    Gill JS, Tonelli M, Mix CH, Johnson N, Pereira BJ.
    Kidney Int; 2004 Feb 15; 65(2):692-9. PubMed ID: 14717943
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.
    Transpl Int; 2002 Sep 15; 15(8):387-92. PubMed ID: 12221456
    [Abstract] [Full Text] [Related]

  • 10. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J.
    Transplantation; 2004 Jan 27; 77(2):244-51. PubMed ID: 14742989
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
    Gonzalez Molina M, Seron D, Garcia del Moral R, Carrera M, Sola E, Jesus Alferez M, Gomez Ullate P, Capdevila L, Gentil MA.
    Transplantation; 2004 Jan 27; 77(2):215-20. PubMed ID: 14742984
    [Abstract] [Full Text] [Related]

  • 12. Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
    Kuypers DR, Malaise J, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20 Suppl 2():ii33-9, ii62. PubMed ID: 15814548
    [Abstract] [Full Text] [Related]

  • 13. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M, Banasik M, Patrzałek D, Klinger M.
    Ann Transplant; 2006 May 27; 11(2):51-6. PubMed ID: 17494290
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results.
    Reich DJ, Clavien PA, Hodge EE, MMF Renal Dysfunction after Liver Transplantation Working Group.
    Transplantation; 2005 Jul 15; 80(1):18-25. PubMed ID: 16003228
    [Abstract] [Full Text] [Related]

  • 15. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Lederer SR, Friedrich N, Banas B, Welser G, Albert ED, Sitter T.
    Clin Transplant; 2005 Apr 15; 19(2):168-74. PubMed ID: 15740551
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil but not the type of calcineurin inhibitor (cyclosporine vs tacrolimus) influences the intragraft mRNA expression of cytokines in human kidney allograft biopsies by in situ RT-PCR analysis.
    Kaminska D, Tyran B, Mazanowska O, Letachowicz W, Kochman A, Rabczynski J, Szyber P, Patrzalek D, Chudoba P, Klinger M.
    Transplant Proc; 2005 Mar 15; 37(2):770-2. PubMed ID: 15848526
    [Abstract] [Full Text] [Related]

  • 17. Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution.
    McGrath JS, Shehata M.
    Transplant Proc; 2001 May 15; 33(3):2193-5. PubMed ID: 11377500
    [No Abstract] [Full Text] [Related]

  • 18. Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.
    El-Agroudy AE, El-Dahshan KF, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Clin Exp Nephrol; 2009 Feb 15; 13(1):66-72. PubMed ID: 18716711
    [Abstract] [Full Text] [Related]

  • 19. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
    Pape L, Ehrich JH, Offner G.
    Clin Transplant; 2004 Oct 15; 18(5):576-9. PubMed ID: 15344963
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE.
    Transplantation; 2003 Jun 27; 75(12):2048-53. PubMed ID: 12829910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.